Investment Visual

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Research and development, 2025: €304M
YoY, 2025: −1.1%
5-year CAGR: +3.1%
10-year CAGR: +22.3%

Research and development

Research and development by fiscal year

Period	Ended	R&D	YoY	Filing
2025	Dec 31, 2025	€304M	−1.1%	20-F, Feb 11, 2026
2024	Dec 31, 2024	€307M	−25.7%	20-F, Feb 12, 2025
2023	Dec 31, 2023	€413M	+8.9%	20-F, Feb 7, 2024
2022	Dec 31, 2022	€380M	+28.3%	20-F, Feb 16, 2023
2021	Dec 31, 2021	€296M	+13.4%	20-F, Mar 2, 2022
2020	Dec 31, 2020	€261M	+36.2%	20-F, Mar 10, 2021
2019	Dec 31, 2019	€192M	+36.6%	20-F, Apr 3, 2020
2018	Dec 31, 2018	€140M	+40.9%	20-F, Apr 3, 2019
2017	Dec 31, 2017	€100M	+50.8%	20-F, Mar 28, 2018
2016	Dec 31, 2016	€66M	+62.9%	20-F, Mar 28, 2018
2015	Dec 31, 2015	€41M	—	20-F, Mar 28, 2018